
Doximity
🇺🇸 NYSE:DOCS
Doximity Q3 2025 Earnings Report
Key Takeaways
Doximity reported strong fiscal Q3 2025 results with revenue of $168.6 million, up 25% YoY. Net income surged 57% to $75.2 million, and adjusted EBITDA increased 39% to $102.0 million, reflecting solid profitability and operational efficiency.
Doximity Revenue
Doximity EPS
Forward Guidance
Doximity expects fiscal Q4 2025 revenue between $132.5 million and $133.5 million, with adjusted EBITDA guidance of $62.5 million to $63.5 million. Full-year revenue is projected between $564.6 million and $565.6 million.
Positive Outlook
- Strong revenue growth driven by increasing engagement on platform.
- AI tools showing significant adoption with 60% QoQ growth.
- Improved profitability with higher adjusted EBITDA margins.
- Solid free cash flow generation of $63.4 million.
- Expansion in platform usage among medical professionals.
Challenges Ahead
- Projected revenue for Q4 indicates a sequential decline.
- Macroeconomic uncertainty may impact client spending.
- High reliance on subscription revenue with potential churn risks.
- Operating expenses increased YoY across key segments.
- Stock-based compensation remains a significant cost factor.